Immune escape mechanisms of childhood ALL and a potential countering role for DC-like leukemia cells-Reference-Cited by-同舟云学术

Immune escape mechanisms of childhood ALL and a potential countering role for DC-like leukemia cells

Published:2002-03 Issue:2 Volume:4 Page:165-175
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Han P.,Story C.,McDonald T.,Mrozik K.,Snell L.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference38 articles.

1. Graft-versusleukaemia reactions after bone marrow transplantation;Horowitz;Blood,1990

2. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen;Cardoso;Blood,1996

3. AML-derived immunomodulatory factor(s) inhibit T cell cytokine secretion and proliferation via inhibition of NF-ATc activation and failure to upregulate c-MYC (Abstract);Buggins;Blood,1999

4. Protective and therapeutic immunity against leukemia induced by irradiated B7-1 (CD80)-transduced leukemia cells;Hirano;Hum Gene Ther,1997

5. CD80- transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens;Mutis;Blood,1998

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Sequential inotuzumab, blinatumomab, and chemotherapy with concurrent donor lymphocyte infusions induce complete remission in relapsed pre‐B acute lymphoblastic leukemia;eJHaem;2024-05-15

2. Post-Hematopoietic Cell Transplantation Relapsed Acute Lymphoblastic Leukemia: Current Challenges and Future Directions;OncoTargets and Therapy;2023-01

3. Different sensitivity of CD19-positive bone marrow and lymph node lymphoblasts may cause resistance to blinatumomab in relapsed B-cell acute lymphoblastic leukemia/lymphoma;Leukemia & Lymphoma;2020-01-03

4. Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment;Current Problems in Cancer;2019-06

5. Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Different Characteristics between Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia;Biology of Blood and Marrow Transplantation;2014-07